Monitor the IPO pricing and listing on Nasdaq (expected symbols: RREVU for units, RREV for shares, RREVW for warrants). The 24-month deadline and management's prior SPAC track record (including RMG III's liquidation) are key risk factors. Track any subsequent S-1 amendments for pricing updates and target business announcements.
Executive Summary
RRE Ventures Acquisition Corp. filed Amendment No. 2 to its S-1 registration statement for a $250 million SPAC IPO, offering 25 million units at $10.00 each. The company is a blank check company targeting technology, defense, AI, and energy sectors, with a 24-month window to complete a business combination. The filing updates the prospectus with revised financial disclosures and legal opinions but does not change the offering's core terms.
Key Financial Metrics
Key Facts
- Offering 25,000,000 units at $10.00 per unit for gross proceeds of $250,000,000
- Each unit consists of one Class A ordinary share and one-third of one redeemable warrant
- Warrants exercisable at $11.50 per share, expiring 5 years after business combination
- Sponsor (RRE Sponsor, LLC) purchased 9,583,333 founder shares for $25,000 (~$0.003/share)
- Sponsor committed to buy 4,510,000 private placement warrants at $1.00 each ($4,510,000 total)
- Underwriter to purchase 2,500,000 private placement warrants at $1.00 each
- Up to $250,000,000 (or $287.5M with over-allotment) to be placed in trust account
- 24 months from closing to complete initial business combination
- Target enterprise value range of approximately $800 million to $4.0 billion
- Net tangible book value deficit of $(309,002) as of March 13, 2026
- Pro forma NTBV per share ranges from $7.23 (0% redemption) to $0.11 (maximum redemption)
- Public shareholders will experience immediate and substantial dilution (~98.9% in max redemption scenario)
- Company has no operating history and has generated no revenues to date
- Management team has prior SPAC experience including RMG I, RMG II, and RMG III
Financial Impact
IPO gross proceeds of $250,000,000 from 25,000,000 units at $10.00 each, with potential additional $37.5M from over-allotment. Sponsor paid $25,000 for founder shares now valued at ~$83.3M at IPO price. Pro forma NTBV per share ranges from $7.23 to $0.11 depending on redemptions.
Risk Factors
- No target business identified; may fail to complete business combination within 24 months
- Immediate and substantial dilution for public shareholders (sponsor paid ~$0.003/share vs $10.00 IPO price)
- Prior SPAC RMG III failed to complete a business combination and liquidated in 2025
- Conflicts of interest with sponsor and management who have interests in other SPACs
- Potential classification as an investment company under the Investment Company Act
- Warrants may expire worthless if no business combination is completed
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001193125-26-181447 |
| Document: d114015dex102.htm | 0001193125-26-181447 |
| Document: d114015dex52.htm | 0001193125-26-181447 |
| Document: d114015dex51.htm | 0001193125-26-181447 |
| Document: d114015dex231.htm | 0001193125-26-181447 |
| Document: 0001193125-26-181447-index-headers.html | 0001193125-26-181447 |
| Document: 0001193125-26-181447-index.html | 0001193125-26-181447 |
| Document: 0001193125-26-181447.txt | 0001193125-26-181447 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 1, 2026 25w ago | 8-K | — | awaiting T+20 | — | — |
Apr 29, 2026 25w ago | 3 | — | awaiting T+20 | — | — |
Apr 29, 2026 25w ago | 3 | — | awaiting T+20 | — | — |
Apr 27, 2026 26w ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers